Related Experiment Video
Updated: Jul 7, 2026

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
The nutritional and metabolic support of heart failure in the intensive care unit
Joseph S Meltzer1, Vivek K Moitra
1Division of Critical Care Medicine, Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York, NY 10032, USA. jm2650@columbia.edu
Insights
Nutritional and metabolic support, including supplements and intensive insulin therapy, can improve outcomes for critically ill heart failure patients in the ICU. Shifting the metabolic state to anabolic is key.
Area of Science:
- Cardiology
- Critical Care Medicine
- Nutritional Science
Background:
- Heart failure and cardiovascular disease are leading causes of ICU admissions.
- Nutritional deficiencies are linked to the progression of chronic heart failure.
- Optimizing nutritional and metabolic support may enhance outcomes in critically ill heart failure patients.
Purpose of the Study:
- To review the role of nutritional and metabolic support in the intensive care unit (ICU) for heart failure patients.
- To analyze current evidence on interventions for critically ill heart failure patients.
Main Methods:
- Literature review of nutritional and metabolic support strategies in acute heart failure care.
- Analysis of studies on cardiac cachexia, nutritional supplements, intensive insulin therapy, and statin use.
Main Results:
- Cardiac cachexia involves inflammation and anabolic-catabolic imbalance.
- Supplements (selenium, vitamins, antioxidants) may support the failing myocardium.
- Intensive insulin therapy shows utility in critically ill patients; statins have an emerging role.
Conclusions:
- Key nutritional support strategies include shifting metabolism to anabolic, reducing oxidative stress, and managing inflammation.
- Tight glycemic control via intensive insulin therapy is increasingly important in critical care.
- Glucose-insulin-potassium therapy is not recommended for heart failure or acute myocardial infarction.
Purpose Of Review:
Heart failure and cardiovascular disease are common causes of morbidity and mortality, contributing to many ICU admissions. Nutritional deficiencies have been associated with the development and worsening of chronic heart failure. Nutritional and metabolic support may improve outcomes in critically ill patients with heart failure. This review analyzes the role of this support in the acute care setting of the ICU.
Recent Findings:
Cardiac cachexia is a complex pathophysiologic process. It is characterized by inflammation and anabolic-catabolic imbalance. Nutritional supplements containing selenium, vitamins and antioxidants may provide needed support to the failing myocardium. Evidence shows that there is utility in intensive insulin therapy in the critically ill. Finally, there is an emerging metabolic role for HMG-CoA reductase inhibition, or statin therapy, in the treatment of heart failure.
Summary:
Shifting the metabolic milieu from catabolic to anabolic, reducing free radicals, and quieting inflammation in addition to caloric supplementation may be the key to nutritional support in the heart failure patient. Tight glycemic control with intensive insulin therapy plays an expanding role in the care of the critically ill. Glucose-insulin-potassium therapy probably does not improve the condition of the patient with heart failure or acute myocardial infarction.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Heart Failure V: Medical Management
Mitral Regurgitation IV: Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...